
|Articles|November 15, 2004
Carl Zeiss Meditec, LDT sale a boon for glaucoma detection
Dublin, CA-The acquisition of San Diego-based Laser Diagnostic Technologies Inc. (LDT) by global device manufacturer and distributor Carl Zeiss Meditec Inc. will give greater exposure to the former company's single product-a novel technology for detecting glaucoma.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
3
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5















































.png)


